Biopharma Cold Chain Logistics Market Expected to Reach USD 51.58 Billion by 2034| CAGR: 10.98%

The global biopharma cold chain logistics market size is expected to reach USD 51.58 Billion by 2034 according to a new study by Polaris Market Research. The Report “Biopharma Cold Chain Logistics Market Share, Size, Trends, Industry Analysis Report, By Component (Storage, Transportation, and Monitoring Components, and Software); By Regions -Market Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global market is anticipated to grow owing to the necessity of cold chain infrastructure in the supply chain network for the temperature sensitive vaccines and drugs, cost containment measures, and technology enabled services for real time monitoring. Moreover, government’s positive initiatives to reduce the wastage and enhancement of services at the local level is also expected to boost the investments in the concerned market.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link: https://www.polarismarketresearch.com/industry-analysis/biopharma-cold-chain-logistics-market/request-for-sample

The market is fragmented based on type, component, and region. In terms of type, the market is segmented into cold and non-cold. Based on component, the biopharma cold chain logistics market is bifurcated as storage, transportation, and monitoring components. Storage segment is further segmented as warehouse, and refrigerated container. Transportation is further segregated as sea freight logistics, air freight logistics, and overland logistics. Monitoring components is bifurcated as hardware and software.

Segment Highlight

• The storage segment accounted for the largest revenue share in 2024 and is expected to continue its dominance over the forecast period on account of the growing demand for temperature-sensitive pharmaceuticals.
   
• Monitoring components segment is expected to witness significant growth over the projected period on account of the increasing need to maintain safety and integrity of the biopharmaceuticals
   
• North America accounted for the largest revenue share in 2024 owing to the growing demand for biopharma cold chain logistics and presence of several market players operating in the U.S. and Canada

List of Key Players

• Air Canada
• DB Schenker
• Kuehne+ Nagel
• United Parcel Service of America, Inc.
• Deutsche Post AG

Polaris Market Research has segmented the biopharma cold chain logistics market report on the basis of component and region

Biopharma Cold Chain Logistics, Component Outlook (Revenue - USD Billion, 2020 – 2034)

• Storage
  • Warehouse
  • Refrigerated Container
• Transportation
  • Sea Freight Logistics
  • Air Freight Logistics
  • Overland Logistics
• Monitoring Components
  • Hardware
    • Sensors
    • RFID Devices
    • Telematics
    • Networking Devices
  • Software

Biopharma Cold Chain Logistics, Regional Outlook (Revenue - USD Billion, 2020 – 2034)

• North America
  • U.S.
  • Canada
• Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
• Latin America
  • Mexico
  • Brazil
  • Argentina

• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa